Coagulo Medical Technologies has created a portable precision-medicine platform that employs connected diagnostic tools for real-time blood coagulation monitoring. This technology provides immediate and accurate assessments of coagulation status in patients, which is critical for informed treatment decisions in emergency care.
Funding
$6.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current blood coagulation monitoring methods often lack the precision needed to pinpoint specific abnormalities in the clotting cascade, hindering personalized treatment strategies. Existing technologies may not provide immediate results, delaying critical decisions in emergency care scenarios. The lack of point-of-care solutions limits accessibility and timely intervention for patients requiring frequent coagulation assessments.
Solution
Coagulo Medical Technologies offers a precision-medicine platform designed for real-time blood coagulation monitoring, enabling personalized management of coagulation disorders. Their connected diagnostic tools provide immediate and accurate assessments of a patient's coagulation status, identifying abnormalities across the entire clotting cascade. This technology delivers clinically valuable information, facilitating informed treatment decisions at the point of care. The platform aims to improve patient outcomes by enabling timely and targeted interventions based on comprehensive coagulation profiling.
Target Audience
The primary target audience includes healthcare providers in emergency care settings, hematologists, and other clinicians managing patients with coagulation disorders.
Features
- Portable diagnostic tools for point-of-care blood coagulation monitoring
- Real-time assessment of coagulation status
- Identification of abnormalities across the entire clotting cascade
- Connected platform for data capture and analysis